Nuwellis prices $6M public offering of 20M shares with warrants at $0.30 each

Nuwellis, Inc. announced a public offering of 20 million shares of common stock and accompanying warrants priced at $0.30 each, aiming to raise approximately $6 million. The offering includes Series C and Series D warrants with exercise prices set at $0.30, exercisable for five years after stockholder approval and a reverse stock split. The company also conducted a private placement to reprice existing warrants to $0.30, pending stockholder approval. Proceeds are expected to support Nuwellis' growth and development in medical technology for cardiorenal conditions.